Nickolas Zaller
Concepts (349)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 65 | 2025 | 394 | 10.610 |
Why?
| | Prisoners | 36 | 2024 | 92 | 7.200 |
Why?
| | Substance Abuse, Intravenous | 23 | 2020 | 43 | 5.190 |
Why?
| | Opioid-Related Disorders | 21 | 2024 | 404 | 4.650 |
Why?
| | Prisons | 24 | 2022 | 37 | 3.910 |
Why?
| | Substance-Related Disorders | 27 | 2024 | 615 | 3.290 |
Why?
| | Opiate Substitution Treatment | 12 | 2022 | 107 | 3.200 |
Why?
| | Analgesics, Opioid | 18 | 2022 | 601 | 3.110 |
Why?
| | Health Services Accessibility | 15 | 2025 | 444 | 3.010 |
Why?
| | Homosexuality, Male | 21 | 2025 | 54 | 3.000 |
Why?
| | Hepatitis C | 11 | 2021 | 80 | 2.800 |
Why?
| | Methadone | 13 | 2020 | 184 | 2.470 |
Why?
| | Criminal Law | 11 | 2024 | 34 | 2.450 |
Why?
| | Patient Acceptance of Health Care | 12 | 2024 | 351 | 2.140 |
Why?
| | Mental Disorders | 13 | 2024 | 427 | 2.050 |
Why?
| | Adult | 90 | 2025 | 14205 | 2.000 |
Why?
| | Risk-Taking | 16 | 2020 | 114 | 1.970 |
Why?
| | Humans | 157 | 2025 | 52441 | 1.930 |
Why?
| | Buprenorphine | 8 | 2024 | 155 | 1.840 |
Why?
| | Mass Screening | 13 | 2023 | 354 | 1.830 |
Why?
| | Health Knowledge, Attitudes, Practice | 16 | 2025 | 504 | 1.800 |
Why?
| | Bisexuality | 6 | 2018 | 20 | 1.720 |
Why?
| | Mental Health Services | 6 | 2024 | 207 | 1.680 |
Why?
| | Telemedicine | 7 | 2024 | 490 | 1.590 |
Why?
| | Syringes | 6 | 2014 | 11 | 1.560 |
Why?
| | Rhode Island | 26 | 2018 | 30 | 1.550 |
Why?
| | Male | 97 | 2025 | 26874 | 1.530 |
Why?
| | Rural Population | 10 | 2025 | 587 | 1.520 |
Why?
| | Harm Reduction | 4 | 2020 | 8 | 1.520 |
Why?
| | Naloxone | 9 | 2016 | 85 | 1.500 |
Why?
| | United States | 38 | 2025 | 5215 | 1.430 |
Why?
| | Methamphetamine | 3 | 2024 | 189 | 1.430 |
Why?
| | Hepacivirus | 8 | 2021 | 103 | 1.400 |
Why?
| | Young Adult | 42 | 2025 | 4346 | 1.400 |
Why?
| | Sexual Behavior | 12 | 2022 | 127 | 1.390 |
Why?
| | Drug Overdose | 13 | 2020 | 161 | 1.370 |
Why?
| | Female | 81 | 2025 | 28277 | 1.330 |
Why?
| | Anti-HIV Agents | 5 | 2024 | 46 | 1.310 |
Why?
| | Alcohol Drinking | 8 | 2017 | 235 | 1.300 |
Why?
| | Middle Aged | 54 | 2025 | 13133 | 1.290 |
Why?
| | Pharmacists | 7 | 2014 | 150 | 1.260 |
Why?
| | Pharmacies | 6 | 2014 | 61 | 1.250 |
Why?
| | Prevalence | 24 | 2025 | 1016 | 1.240 |
Why?
| | Needle-Exchange Programs | 5 | 2020 | 5 | 1.210 |
Why?
| | Health Status Disparities | 6 | 2021 | 218 | 1.190 |
Why?
| | Attitude of Health Personnel | 6 | 2017 | 358 | 1.140 |
Why?
| | Amphetamine-Related Disorders | 4 | 2024 | 93 | 1.070 |
Why?
| | Unsafe Sex | 8 | 2020 | 27 | 1.050 |
Why?
| | Healthcare Disparities | 3 | 2023 | 291 | 1.030 |
Why?
| | Urban Population | 4 | 2023 | 161 | 1.020 |
Why?
| | Sexually Transmitted Diseases | 7 | 2016 | 36 | 1.010 |
Why?
| | Minority Groups | 7 | 2022 | 136 | 1.010 |
Why?
| | China | 20 | 2025 | 135 | 0.960 |
Why?
| | Socioeconomic Factors | 19 | 2021 | 609 | 0.940 |
Why?
| | Cross-Sectional Studies | 24 | 2025 | 1677 | 0.930 |
Why?
| | Continuity of Patient Care | 3 | 2017 | 53 | 0.880 |
Why?
| | Criminals | 4 | 2020 | 23 | 0.880 |
Why?
| | Adolescent | 33 | 2025 | 6713 | 0.870 |
Why?
| | Alcoholism | 4 | 2021 | 236 | 0.860 |
Why?
| | Delivery of Health Care | 5 | 2023 | 317 | 0.820 |
Why?
| | Pandemics | 6 | 2024 | 580 | 0.790 |
Why?
| | Mental Health | 2 | 2023 | 237 | 0.760 |
Why?
| | Urinary Bladder Diseases | 1 | 2022 | 17 | 0.750 |
Why?
| | Community Pharmacy Services | 3 | 2014 | 71 | 0.750 |
Why?
| | Narcotic Antagonists | 10 | 2018 | 150 | 0.750 |
Why?
| | Research | 1 | 2022 | 109 | 0.740 |
Why?
| | Transients and Migrants | 4 | 2015 | 22 | 0.740 |
Why?
| | Influenza Vaccines | 1 | 2022 | 36 | 0.730 |
Why?
| | Yoga | 1 | 2020 | 15 | 0.680 |
Why?
| | Sexual Partners | 10 | 2025 | 40 | 0.660 |
Why?
| | Substance Abuse Treatment Centers | 5 | 2024 | 81 | 0.650 |
Why?
| | Pilot Projects | 7 | 2024 | 725 | 0.650 |
Why?
| | Public Health | 5 | 2022 | 224 | 0.640 |
Why?
| | Arkansas | 11 | 2025 | 2013 | 0.630 |
Why?
| | Health Services | 3 | 2011 | 66 | 0.600 |
Why?
| | Heterosexuality | 4 | 2015 | 9 | 0.590 |
Why?
| | Health Personnel | 2 | 2022 | 255 | 0.590 |
Why?
| | Racism | 1 | 2020 | 55 | 0.590 |
Why?
| | Prescription Drug Misuse | 3 | 2015 | 31 | 0.590 |
Why?
| | Rural Health Services | 1 | 2020 | 177 | 0.560 |
Why?
| | Community Integration | 1 | 2017 | 1 | 0.540 |
Why?
| | Logistic Models | 9 | 2024 | 930 | 0.540 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 175 | 0.540 |
Why?
| | Coronavirus Infections | 1 | 2020 | 188 | 0.530 |
Why?
| | Condoms | 8 | 2025 | 28 | 0.520 |
Why?
| | Social Stigma | 1 | 2017 | 50 | 0.520 |
Why?
| | Multivariate Analysis | 8 | 2021 | 601 | 0.520 |
Why?
| | Risk Factors | 20 | 2025 | 3971 | 0.520 |
Why?
| | Health Policy | 3 | 2015 | 162 | 0.510 |
Why?
| | Social Class | 1 | 2017 | 97 | 0.510 |
Why?
| | Workplace | 2 | 2015 | 96 | 0.500 |
Why?
| | Drug Users | 3 | 2016 | 16 | 0.500 |
Why?
| | Health Literacy | 1 | 2018 | 131 | 0.500 |
Why?
| | Sexuality | 2 | 2016 | 14 | 0.500 |
Why?
| | Social Justice | 2 | 2022 | 26 | 0.490 |
Why?
| | Crime | 3 | 2020 | 27 | 0.480 |
Why?
| | Minority Health | 1 | 2015 | 10 | 0.470 |
Why?
| | HIV Seropositivity | 2 | 2013 | 28 | 0.470 |
Why?
| | HIV | 4 | 2018 | 26 | 0.470 |
Why?
| | Blood Donors | 2 | 2006 | 21 | 0.450 |
Why?
| | Qualitative Research | 5 | 2022 | 365 | 0.440 |
Why?
| | Case Management | 3 | 2015 | 43 | 0.420 |
Why?
| | Heroin Dependence | 6 | 2018 | 44 | 0.410 |
Why?
| | Feasibility Studies | 5 | 2024 | 404 | 0.400 |
Why?
| | Crisis Intervention | 2 | 2024 | 11 | 0.400 |
Why?
| | Community Health Workers | 2 | 2024 | 58 | 0.380 |
Why?
| | Pain | 1 | 2015 | 373 | 0.370 |
Why?
| | Aged | 12 | 2022 | 10242 | 0.360 |
Why?
| | Confined Spaces | 3 | 2018 | 3 | 0.350 |
Why?
| | Ambulatory Care | 3 | 2018 | 238 | 0.350 |
Why?
| | Attitude to Health | 2 | 2011 | 191 | 0.350 |
Why?
| | Equipment Contamination | 2 | 2010 | 20 | 0.350 |
Why?
| | Comorbidity | 7 | 2021 | 637 | 0.340 |
Why?
| | Patient Discharge | 3 | 2021 | 320 | 0.340 |
Why?
| | Medicaid | 3 | 2022 | 264 | 0.340 |
Why?
| | Hepatitis, Viral, Human | 2 | 2010 | 10 | 0.330 |
Why?
| | Interviews as Topic | 5 | 2020 | 270 | 0.320 |
Why?
| | Contraceptives, Postcoital | 1 | 2010 | 1 | 0.320 |
Why?
| | Behind-the-Counter Drugs | 1 | 2010 | 1 | 0.320 |
Why?
| | Contraception, Postcoital | 1 | 2009 | 4 | 0.320 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 82 | 0.310 |
Why?
| | Judicial Role | 2 | 2018 | 6 | 0.300 |
Why?
| | Disease Outbreaks | 2 | 2009 | 121 | 0.300 |
Why?
| | Health Services Needs and Demand | 3 | 2023 | 161 | 0.290 |
Why?
| | Prescription Drugs | 3 | 2014 | 40 | 0.290 |
Why?
| | Health Promotion | 2 | 2023 | 271 | 0.290 |
Why?
| | Program Evaluation | 3 | 2020 | 351 | 0.290 |
Why?
| | Self Report | 3 | 2020 | 221 | 0.280 |
Why?
| | Ukraine | 2 | 2020 | 5 | 0.280 |
Why?
| | Self Care | 2 | 2019 | 136 | 0.280 |
Why?
| | Staphylococcal Infections | 1 | 2010 | 270 | 0.270 |
Why?
| | Narcotics | 4 | 2013 | 109 | 0.270 |
Why?
| | Forensic Psychiatry | 1 | 2007 | 6 | 0.270 |
Why?
| | Anti-Retroviral Agents | 2 | 2020 | 19 | 0.270 |
Why?
| | Motivation | 3 | 2022 | 283 | 0.260 |
Why?
| | Alcohol-Related Disorders | 3 | 2015 | 43 | 0.250 |
Why?
| | Cocaine-Related Disorders | 3 | 2017 | 206 | 0.250 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2018 | 168 | 0.230 |
Why?
| | Police | 2 | 2016 | 4 | 0.230 |
Why?
| | Longitudinal Studies | 7 | 2025 | 756 | 0.230 |
Why?
| | Nutrition Surveys | 2 | 2015 | 119 | 0.230 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2022 | 393 | 0.230 |
Why?
| | Blood Transfusion | 1 | 2006 | 126 | 0.230 |
Why?
| | Severity of Illness Index | 4 | 2021 | 1045 | 0.220 |
Why?
| | Sex Factors | 4 | 2017 | 735 | 0.210 |
Why?
| | Hospitals, Psychiatric | 1 | 2023 | 15 | 0.200 |
Why?
| | Vaccination | 2 | 2022 | 294 | 0.200 |
Why?
| | Hepatitis C, Chronic | 2 | 2016 | 86 | 0.190 |
Why?
| | Law Enforcement | 3 | 2022 | 9 | 0.190 |
Why?
| | Infection Control | 2 | 2020 | 46 | 0.180 |
Why?
| | Housing | 1 | 2022 | 48 | 0.180 |
Why?
| | Ownership | 1 | 2021 | 17 | 0.180 |
Why?
| | Suicide | 1 | 2022 | 85 | 0.180 |
Why?
| | Drug Monitoring | 2 | 2012 | 81 | 0.180 |
Why?
| | Baltimore | 2 | 2020 | 28 | 0.180 |
Why?
| | Geography | 1 | 2021 | 65 | 0.170 |
Why?
| | Masks | 1 | 2021 | 27 | 0.170 |
Why?
| | Incidence | 4 | 2019 | 1096 | 0.170 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2021 | 50 | 0.170 |
Why?
| | Wounds, Gunshot | 1 | 2021 | 34 | 0.170 |
Why?
| | Follow-Up Studies | 6 | 2018 | 2294 | 0.170 |
Why?
| | Geriatrics | 1 | 2021 | 41 | 0.170 |
Why?
| | Southeastern United States | 1 | 2020 | 49 | 0.170 |
Why?
| | Awareness | 1 | 2020 | 26 | 0.160 |
Why?
| | Needle Sharing | 2 | 2012 | 4 | 0.160 |
Why?
| | Models, Theoretical | 1 | 2021 | 181 | 0.160 |
Why?
| | Knowledge | 1 | 2020 | 28 | 0.160 |
Why?
| | Primary Health Care | 1 | 2024 | 387 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 73 | 0.160 |
Why?
| | Chronic Pain | 1 | 2022 | 189 | 0.160 |
Why?
| | Prejudice | 1 | 2020 | 37 | 0.160 |
Why?
| | Kenya | 1 | 2019 | 11 | 0.160 |
Why?
| | Universities | 1 | 2020 | 174 | 0.150 |
Why?
| | Emergency Service, Hospital | 2 | 2014 | 521 | 0.150 |
Why?
| | Reproducibility of Results | 1 | 2022 | 1223 | 0.150 |
Why?
| | Hospitals | 2 | 2021 | 182 | 0.150 |
Why?
| | Demography | 2 | 2018 | 92 | 0.150 |
Why?
| | Reproductive Health | 2 | 2015 | 8 | 0.150 |
Why?
| | Survival Rate | 1 | 2021 | 944 | 0.150 |
Why?
| | Puerto Rico | 1 | 2018 | 17 | 0.150 |
Why?
| | Health Behavior | 2 | 2018 | 256 | 0.150 |
Why?
| | Smoking | 1 | 2022 | 514 | 0.140 |
Why?
| | Mouth | 1 | 2018 | 33 | 0.140 |
Why?
| | Health Status | 1 | 2020 | 300 | 0.140 |
Why?
| | Pennsylvania | 2 | 2016 | 29 | 0.140 |
Why?
| | Sex Distribution | 2 | 2015 | 138 | 0.140 |
Why?
| | Age Distribution | 2 | 2015 | 176 | 0.140 |
Why?
| | Office Visits | 1 | 2018 | 45 | 0.140 |
Why?
| | Stress, Psychological | 2 | 2022 | 275 | 0.140 |
Why?
| | Age Factors | 3 | 2018 | 1120 | 0.140 |
Why?
| | Emigrants and Immigrants | 1 | 2018 | 39 | 0.130 |
Why?
| | Naltrexone | 1 | 2018 | 69 | 0.130 |
Why?
| | Referral and Consultation | 4 | 2022 | 288 | 0.130 |
Why?
| | Massachusetts | 3 | 2012 | 32 | 0.130 |
Why?
| | Binge Drinking | 1 | 2017 | 25 | 0.130 |
Why?
| | Hepatitis C Antibodies | 1 | 2016 | 19 | 0.130 |
Why?
| | Biomedical Research | 1 | 2020 | 260 | 0.130 |
Why?
| | Drug Administration Schedule | 2 | 2015 | 370 | 0.120 |
Why?
| | Cohort Studies | 3 | 2018 | 1576 | 0.120 |
Why?
| | Health Care Surveys | 3 | 2013 | 177 | 0.120 |
Why?
| | Education | 1 | 2016 | 39 | 0.120 |
Why?
| | Connecticut | 5 | 2013 | 16 | 0.120 |
Why?
| | Cooperative Behavior | 2 | 2017 | 224 | 0.120 |
Why?
| | Depression | 2 | 2018 | 603 | 0.120 |
Why?
| | Medication Adherence | 2 | 2013 | 133 | 0.120 |
Why?
| | Homosexuality, Female | 1 | 2015 | 10 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2016 | 122 | 0.120 |
Why?
| | Education, Medical, Continuing | 1 | 2016 | 76 | 0.120 |
Why?
| | Abortion, Induced | 1 | 2015 | 22 | 0.110 |
Why?
| | Cocaine | 1 | 2016 | 168 | 0.110 |
Why?
| | Bayes Theorem | 2 | 2025 | 122 | 0.110 |
Why?
| | Community Health Centers | 1 | 2015 | 30 | 0.110 |
Why?
| | Prescriptions | 2 | 2014 | 11 | 0.110 |
Why?
| | Health Surveys | 2 | 2013 | 238 | 0.110 |
Why?
| | Nonprescription Drugs | 2 | 2014 | 33 | 0.110 |
Why?
| | Pain Measurement | 1 | 2015 | 263 | 0.100 |
Why?
| | Coercion | 1 | 2013 | 9 | 0.100 |
Why?
| | Utilization Review | 1 | 2013 | 31 | 0.100 |
Why?
| | Syphilis | 1 | 2013 | 20 | 0.100 |
Why?
| | Neoplasms | 1 | 2023 | 1314 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2013 | 89 | 0.100 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2016 | 208 | 0.100 |
Why?
| | Pain Management | 1 | 2015 | 187 | 0.100 |
Why?
| | Attitude | 1 | 2013 | 73 | 0.100 |
Why?
| | Time Factors | 3 | 2018 | 2987 | 0.100 |
Why?
| | Behavior, Addictive | 1 | 2013 | 60 | 0.100 |
Why?
| | Clinical Pharmacy Information Systems | 1 | 2012 | 2 | 0.100 |
Why?
| | AIDS Serodiagnosis | 2 | 2015 | 9 | 0.100 |
Why?
| | Pharmaceutical Services | 1 | 2013 | 52 | 0.100 |
Why?
| | Drug Utilization | 2 | 2010 | 77 | 0.100 |
Why?
| | Community Health Services | 1 | 2013 | 102 | 0.090 |
Why?
| | Organizational Policy | 1 | 2012 | 39 | 0.090 |
Why?
| | Liver Neoplasms | 1 | 2016 | 341 | 0.090 |
Why?
| | Data Collection | 2 | 2011 | 285 | 0.090 |
Why?
| | Health Care Costs | 2 | 2010 | 176 | 0.090 |
Why?
| | Emergency Medical Technicians | 1 | 2011 | 8 | 0.090 |
Why?
| | Antiretroviral Therapy, Highly Active | 2 | 2014 | 32 | 0.090 |
Why?
| | Heroin | 1 | 2012 | 16 | 0.090 |
Why?
| | Alcoholic Intoxication | 1 | 2011 | 24 | 0.090 |
Why?
| | Patient Compliance | 1 | 2013 | 228 | 0.090 |
Why?
| | Academic Medical Centers | 2 | 2009 | 151 | 0.090 |
Why?
| | Methicillin Resistance | 1 | 2010 | 16 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 6694 | 0.080 |
Why?
| | Policy | 1 | 2010 | 27 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2010 | 158 | 0.080 |
Why?
| | Commerce | 1 | 2010 | 42 | 0.080 |
Why?
| | Hepatitis B | 2 | 2007 | 15 | 0.080 |
Why?
| | Contraception Behavior | 1 | 2009 | 12 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2015 | 3449 | 0.080 |
Why?
| | Blood-Borne Pathogens | 2 | 2007 | 6 | 0.080 |
Why?
| | Recurrence | 2 | 2013 | 680 | 0.080 |
Why?
| | Needs Assessment | 2 | 2023 | 141 | 0.080 |
Why?
| | Odds Ratio | 1 | 2010 | 563 | 0.080 |
Why?
| | Interpersonal Relations | 1 | 2010 | 110 | 0.070 |
Why?
| | Veterans | 1 | 2015 | 573 | 0.070 |
Why?
| | Communicable Diseases | 1 | 2009 | 55 | 0.070 |
Why?
| | Disease Transmission, Infectious | 2 | 2006 | 12 | 0.070 |
Why?
| | Self Efficacy | 2 | 2021 | 133 | 0.070 |
Why?
| | Kentucky | 2 | 2018 | 46 | 0.070 |
Why?
| | Ohio | 2 | 2018 | 46 | 0.070 |
Why?
| | Diagnostic Services | 1 | 2007 | 2 | 0.070 |
Why?
| | Equipment Reuse | 1 | 2007 | 2 | 0.070 |
Why?
| | Substance Abuse Detection | 1 | 2007 | 93 | 0.070 |
Why?
| | Vaccines, Combined | 1 | 2007 | 2 | 0.070 |
Why?
| | Hepatitis B Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| | Hepatitis A Vaccines | 1 | 2007 | 3 | 0.070 |
Why?
| | Hepatitis A | 1 | 2007 | 5 | 0.070 |
Why?
| | Urban Health Services | 1 | 2007 | 18 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2013 | 5508 | 0.070 |
Why?
| | Risk Reduction Behavior | 2 | 2018 | 58 | 0.070 |
Why?
| | Public Health Administration | 1 | 2007 | 81 | 0.060 |
Why?
| | Health Expenditures | 1 | 2007 | 74 | 0.060 |
Why?
| | Viral Load | 1 | 2025 | 81 | 0.060 |
Why?
| | Vulnerable Populations | 2 | 2017 | 51 | 0.060 |
Why?
| | Survival Analysis | 1 | 2006 | 656 | 0.060 |
Why?
| | Prospective Studies | 3 | 2018 | 2433 | 0.050 |
Why?
| | Georgia (Republic) | 1 | 2004 | 2 | 0.050 |
Why?
| | Counseling | 2 | 2016 | 133 | 0.050 |
Why?
| | Education, Pharmacy, Continuing | 2 | 2014 | 4 | 0.050 |
Why?
| | Educational Status | 2 | 2015 | 227 | 0.050 |
Why?
| | Public Health Surveillance | 1 | 2022 | 18 | 0.050 |
Why?
| | New England | 2 | 2013 | 10 | 0.050 |
Why?
| | Intention | 1 | 2023 | 48 | 0.050 |
Why?
| | Databases, Factual | 1 | 2025 | 721 | 0.050 |
Why?
| | Jurisprudence | 1 | 2022 | 10 | 0.050 |
Why?
| | Quarantine | 1 | 2022 | 11 | 0.050 |
Why?
| | Genotype | 2 | 2016 | 563 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 106 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2021 | 94 | 0.040 |
Why?
| | Influenza, Human | 1 | 2022 | 90 | 0.040 |
Why?
| | Medicare | 1 | 2022 | 281 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 288 | 0.040 |
Why?
| | Violence | 1 | 2021 | 65 | 0.040 |
Why?
| | Safe Sex | 1 | 2019 | 10 | 0.040 |
Why?
| | Serologic Tests | 1 | 2019 | 24 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 57 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 579 | 0.030 |
Why?
| | Crack Cocaine | 1 | 2017 | 17 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 286 | 0.030 |
Why?
| | Hepatitis B Antibodies | 1 | 2016 | 7 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 128 | 0.030 |
Why?
| | Quality of Life | 1 | 2022 | 893 | 0.030 |
Why?
| | Health Education | 2 | 2007 | 157 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 400 | 0.030 |
Why?
| | Cultural Characteristics | 1 | 2015 | 22 | 0.030 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2015 | 28 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 458 | 0.030 |
Why?
| | Employment | 1 | 2015 | 94 | 0.030 |
Why?
| | Child Abuse, Sexual | 1 | 2015 | 42 | 0.030 |
Why?
| | Mexico | 1 | 2014 | 36 | 0.030 |
Why?
| | Treponema pallidum | 1 | 2013 | 9 | 0.030 |
Why?
| | Social Environment | 1 | 2014 | 82 | 0.030 |
Why?
| | Hospital Rapid Response Team | 1 | 2013 | 2 | 0.030 |
Why?
| | Social Work | 1 | 2013 | 23 | 0.030 |
Why?
| | Social Adjustment | 1 | 2013 | 29 | 0.030 |
Why?
| | Professional Role | 1 | 2014 | 79 | 0.030 |
Why?
| | Epidemics | 1 | 2013 | 26 | 0.030 |
Why?
| | Coinfection | 1 | 2013 | 41 | 0.030 |
Why?
| | Empathy | 1 | 2013 | 47 | 0.030 |
Why?
| | Risk Assessment | 1 | 2018 | 1349 | 0.020 |
Why?
| | Poverty | 1 | 2015 | 218 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2013 | 113 | 0.020 |
Why?
| | Electronic Prescribing | 1 | 2012 | 2 | 0.020 |
Why?
| | Program Development | 1 | 2013 | 164 | 0.020 |
Why?
| | Insurance, Health | 1 | 2013 | 132 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2013 | 123 | 0.020 |
Why?
| | Drug Prescriptions | 1 | 2013 | 112 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 870 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2012 | 130 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2015 | 1202 | 0.020 |
Why?
| | Philadelphia | 1 | 2011 | 11 | 0.020 |
Why?
| | Triage | 1 | 2011 | 66 | 0.020 |
Why?
| | Risk | 1 | 2012 | 315 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2010 | 52 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2010 | 48 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2010 | 93 | 0.020 |
Why?
| | Preventive Health Services | 1 | 2010 | 53 | 0.020 |
Why?
| | Evidence-Based Practice | 1 | 2010 | 108 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 404 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 490 | 0.020 |
Why?
| | Antiviral Agents | 1 | 2010 | 173 | 0.020 |
Why?
| | Child | 1 | 2021 | 7194 | 0.020 |
Why?
| | New York City | 1 | 2008 | 25 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2008 | 53 | 0.020 |
Why?
| | HIV Seroprevalence | 1 | 2007 | 3 | 0.020 |
Why?
| | Cost of Illness | 1 | 2007 | 120 | 0.020 |
Why?
| | Health Services Research | 1 | 2007 | 153 | 0.020 |
Why?
| | Causality | 1 | 2006 | 51 | 0.020 |
Why?
| | Pregnancy | 1 | 2009 | 2642 | 0.010 |
Why?
|
|
Zaller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|